Evidence map›Paper›PMID 27120783›Full record

ArticleOncotarget2016

CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer.

Christine Woischke, Cristina Blaj, Eva Marina Schmidt, Sebastian Lamprecht, Jutta Engel, Heiko Hermeking, Thomas Kirchner, David Horst

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Prognostic Value of SLC4A4 and its Correlation with Immune Infiltration in Colon Adenocarcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A 65‑gene signature for prognostic prediction in colon adenocarcinoma.International journal of molecular medicine · 2018
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Christine WoischkePathologisches Institut, Ludwig-Maximilians-Universität München, München, Germany.
Cristina BlajPathologisches Institut, Ludwig-Maximilians-Universität München, München, Germany.
Eva Marina SchmidtPathologisches Institut, Ludwig-Maximilians-Universität München, München, Germany.
Sebastian LamprechtPathologisches Institut, Ludwig-Maximilians-Universität München, München, Germany.
Jutta EngelTumorregister München, Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität München, München, Germany.
Heiko HermekingPathologisches Institut, Ludwig-Maximilians-Universität München, München, Germany.
Thomas KirchnerPathologisches Institut, Ludwig-Maximilians-Universität München, München, Germany.
David HorstPathologisches Institut, Ludwig-Maximilians-Universität München, München, Germany.
Ludwig-Maximilians-Universität München · DEGerman Cancer Research Center · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancers show significant tumor cell heterogeneity within the same core genetic background. Epithelial-mesenchymal transition (EMT) is an important functional aspect of this heterogeneity and hallmark of colorectal cancer progression. Here, we identify CYB5R1, an enzyme involved in oxidative stress protection and drug metabolism, as an indicator of EMT in colon cancer. We demonstrate high CYB5R1 expression in colorectal cancer cells undergoing EMT at the infiltrative tumor edge and reveal an extraordinarily strong association of CYB5R1 expression with two core EMT gene expression signatures in a large independent colon cancer data set from The Cancer Genome Atlas (TCGA). Furthermore, we demonstrate that CYB5R1 is required for an infiltrative tumor cell phenotype, and robustly linked with poor prognosis in colorectal cancer. Our findings have important implications for colon cancer cells undergoing EMT and may be exploited for diagnostic and therapeutic purposes.

Indexed as

Gene Expression Regulation, NeoplasticAgedBiomarkers, TumorCell Line, TumorColonic NeoplasmsCytochrome-B(5) ReductaseEpithelial-Mesenchymal TransitionFemaleHumansKaplan-Meier EstimateMaleMultivariate AnalysisPrognosisRNA InterferenceTreatment OutcomeBiomarkers, TumorCYB5R1 protein, humanCytochrome-B(5) Reductasecolorectal cancerCYB5R1drug metabolismEMTsurvival

Identifiers

PMID27120783
PMCPMC5058761
OpenAlexW2339383329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.